Exhibitors

Discover the molecular mechanisms and the genetic & genomic aspects of various cancers to develop better and more personalized diagnostic & treatment options. Genomic Profiling: identify genetic mutations, rearrangements, and variations that either drive cancer development or can be used to develop targeted therapies. Tumor Heterogeneity Analysis: identify intratumoral subclones to understand the unique evolution of any given cancer. Personalized Medicine: tailor therapies or monitor treatment responses based on specific tumor profiles with gene panel analysis or by detecting circulating tumor DNA (ctDNA) with liquid biopsy. Biomarker Discovery: identify unique biomarkers that can be used for diagnostic, prognostic, or predictive purposes.